Genprex partners with Roche Diagnostics on biomarker validation for NSCLC
Genprex has collaborated with Roche Diagnostics to validate biomarkers used for patient selection in clinical trials for non-small…
Genprex Shares Rise After Collaboration With Roche Diagnostics
Medical research ©rawpixel Genprex Inc. (NASDAQ:GNPX) shares gained 3% on Monday after the clinical-stage biotechnology company announced a…
With New Phase 3 Data, Roche Claims an Edge Over Amgen and BMS Lung Cancer Drugs
Roche is a relative latecomer in the chase to block a protein called KRAS G12C to treat lung…
Roche divarasib tops KRAS G12C lung cancer drugs
Roche (OTCQX:RHHBY) reported positive phase III Krascendo 1 results for divarasib in previously treated KRAS…
Roche Pharma launches India’s first subcutaneous immunotherapy for lung cancer
Roche Pharma India has announced the launch of Tecentriq® SC (atezolizumab) in India, introducing the country’s first subcutaneous…
As Roche eyes busy 2026, Vabysmo undershoots targets and Tecentriq fails early lung cancer study
Roche is looking to a busy 2026 after 10 new molecules entered late-stage testing last year and as…
GSK inks $10.6B Nuvalent buyout to challenge Roche and Pfizer
GSK has struck a deal to buy Nuvalent for $10.6 billion, securing two near-approval cancer therapies that could challenge…
Roche brings 7-minute lung cancer shot to India
New Delhi: Roche Pharma India has launched the country’s first injectable immunotherapy for lung cancer, allowing patients to…
Roche data at ESMO 2025 showcase advances in science and cancer care across multiple tumour types
F. Hoffmann-La Roche Ltd Basel, 13 October 2025 – Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that…
Roche Receives FDA Nod for Lung Cancer Companion Diagnostic
Summary:The FDA has approved Roche’s VENTANA MET (SP44) RxDx Assay, the first companion diagnostic to identify MET protein…